Schreiner MediPharm has developed in a joint project with the packaging manufacturer Edelmann an innovative solution, which makes important product information accessible without opening the pharmaceutical pack.
The packaging solution is based on the requirements of the EU Falsified Medicines Directive 2011/62/EU.
The EU directive requires a security seal for the outer packaging of medicines to prevent manipulations.
Pharmacists can then only read the package insert after destroying the seal, which is meant to form a barrier and to serve as a first-opening indication.
In order to avoid this, Schreiner MediPharm has jointly developed with Edelmann a novel solution combining a folding box with a booklet-label applied to the outside.
Applied to outer packaging, the multi-page booklet-label from Schreiner MediPharm makes even multi-lingual product information easily accessible and readily visible without damaging the original pack.
It reliably adheres to the medicine pack and is easy to open and close again with the top layer of the film.
The booklet-label is additionally equipped with a security colour-shifting ink for integrated protection against counterfeiting.
Schreiner MediPharm senior sales director Robert Unglert said: "The solution that has been jointly developed with Edelmann maintains the integrity of the pack, while allowing easy access to the package insert."
The patient benefits from the booklet applied to the pack because it is easy to open and close. Since the booklet is firmly attached to the pack, it is also less likely to be misplaced.